354 filings
Page 4 of 18
8-K
2zaa9k0z
9 May 23
Results of Operations and Financial Condition
7:10am
424B5
xhiectbljwyt1
9 May 23
Prospectus supplement for primary offering
7:09am
8-K
hle6irf4ixl0w uyysz
8 May 23
Trevena Announces Approval of OLINVYK in China
12:01pm
8-K
eymu5d3uyvqxdu5r
21 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:02pm
8-K
azi8m7idaxj7mb8
30 Mar 23
Trevena Announces Initial Topline OLINVYK Data from
7:08am
8-K
lax tpvz3u23c
30 Mar 23
Trevena Reports Fourth Quarter 2022 Results and Provides Business Update
7:06am
8-K
wu42qc66 49v3xm5167r
13 Mar 23
Other Events
7:00am
S-8
0nqi9kw00
24 Jan 23
Registration of securities for employees
8:41pm
8-K
caco 4pfm615e9jr964t
9 Jan 23
Regulation FD Disclosure
7:08am
8-K
x0c7fjetgy ja5z
29 Nov 22
Other Events
7:05am
8-K
jxhmxoo
17 Nov 22
Trevena, Inc. Announces $8.0 Million Registered Direct Offering
9:51pm
424B5
4oqnu58e08195w03wwj
17 Nov 22
Prospectus supplement for primary offering
9:49pm
8-K
bsy7ybx7ltsd3nvt5d
9 Nov 22
Trevena Announces Reverse Stock Split
4:06pm
8-K
0gdaynezilwt
9 Nov 22
Trevena Announces Completion of Phase 1 Study for TRV045, Novel S1P Receptor Modulator
7:06am
8-K
o35wrulbn1qyvvk2
9 Nov 22
Trevena Reports Third Quarter 2022 Results and Provides Business Update
7:05am
8-K
wzk3heqar rf
12 Sep 22
Submission of Matters to a Vote of Security Holders
4:05pm
DEFA14A
engo4 1an4qv32
18 Aug 22
Additional proxy soliciting materials
7:05am